SCHEMBL6600499

SCHEMBL6600499

COc1ccc2[nH]cc(CCNC(=O)c3cc(C(C)(C)C)c(O)c(C(C)(C)C)c3)c2c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.74
POLB P06746 1/20 0.74
TRPV1 Q8NER1 9/20 0.69
MTNR1A P48039 6/20 0.66
MTNR1B P49286 3/20 0.65
MEN1 O00255 2/20 0.65
KDM4E B2RXH2 1/20 0.65
ALDH1A1 P00352 1/20 0.65
CYP1A1 P04798 1/20 0.65
MPO P05164 1/20 0.65
CYP1A2 P05177 1/20 0.65
CYP3A4 P08684 1/20 0.65
HTR1A P08908 1/20 0.65
CYP2D6 P10635 1/20 0.65
HPGD P15428 1/20 0.65
NQO2 P16083 1/20 0.65
HTR2B P41595 1/20 0.65
RAB9A P51151 1/20 0.65
BLM P54132 1/20 0.65
PMP22 Q01453 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL798092 0.88 KMT2A (0.80) KMT2APOLBTRPV1MTNR1AMTNR1B
SCHEMBL6919747 0.83 TRPV1 (0.88) KMT2APOLBTRPV1MTNR1AMTNR1B
SCHEMBL28663007 0.81 KMT2A (0.87) KMT2APOLBTRPV1MTNR1AMTNR1B
SCHEMBL6930033 0.81 MTNR1A (0.81) KMT2APOLBTRPV1MTNR1AMTNR1B
SCHEMBL3219747 0.80 KMT2A (0.77) KMT2APOLBTRPV1MTNR1AMTNR1B
SCHEMBL9936354 0.80 TRPV1 (1.00) KMT2APOLBTRPV1MTNR1AMEN1
SCHEMBL23644935 0.79 MTNR1A (0.83) KMT2APOLBTRPV1MTNR1AMTNR1B
Melatonin SCHEMBL4686085 0.79 MTNR1A (1.00) KMT2APOLBMTNR1AMTNR1BMEN1
Melatonin SCHEMBL29349848 0.79 MTNR1A (1.00) KMT2APOLBMTNR1AMTNR1BMEN1
Melatonin SCHEMBL19018 0.79 MTNR1A (1.00) KMT2APOLBMTNR1AMTNR1BMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004085392-A1 MELATONIN DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL DYSFUNCTIONS FAUST PHARMACEUTICALS (FR) 2004-10-07 WO disclosed
WO-2004085395-A1 MELATONIN DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL DYSFUNCTIONS FAUST PHARMACEUTICALS (FR) 2004-10-07 WO disclosed
EP-1462103-A1 NO donors, combination products and uses as modulators of neurotransmitter release Faust Pharmaceuticals (FR) 2004-09-29 EP disclosed